SOURCE: NexMed, Inc.

May 05, 2006 08:31 ET

NexMed to Report First Quarter 2006 Financial Results on Tuesday, May 9, 2006

EAST WINDSOR, NJ -- (MARKET WIRE) -- May 5, 2006 -- NexMed, Inc. (NASDAQ: NEXM), a developer of innovative pharmaceutical products based on its proprietary NexACT® transdermal drug delivery technology, today announced that on Tuesday, May 9, 2006, it expects to report its first quarter 2006 results at 8:30a.m.EST and hold its management conference call at 9:00a.m.EST. The Company intends to file its Form 10-Q for the quarter ended March 31, 2006 on the same day. The call can be accessed in the U.S. by dialing 877-407-9205 and outside of the U.S. by dialing 201-689-8054 and asking the conference operator for the NexMed Conference Call. The conference call will also be Webcast live at Playback is available until May 17, 2006, by dialing in the U.S. 877-660-6853 and outside of the U.S. by dialing 201-612-7415. Replay pass codes 286 and 201870 are both required for playback.

About NexMed, Inc.

NexMed, an innovative drug developer, offers large pharmaceutical companies the opportunity to save considerably on R&D costs, develop new patient-friendly transdermal products, and extend patent lifespans and brand equity, through participation in early stage licensing and development partnerships. NexMed currently has a host of medicines in development, such as treatments for nail fungus, sexual disorders and more, all based on its proprietary NexACT® drug delivery technology.

Contact Information

  • Contacts:
    Deborah Carty
    NexMed, Inc.
    (609) 371-8123 x 159
    Email Contact